Life Sciences/Biotech

JHP Pharma To Buy King Sterile Plant In Rochester For $90 Million

ROCHESTER ? JHP Pharmaceuticals will purchase the sterile manufacturing facility of King Pharmaceuticals in Rochester, some of King?s current products manufactured there and related contract manufacturing business for $90 million, subject to final inventory adjustments. The companies also entered into a manufacturing and supply agreement pursuant to which JHP will provide certain fill and finish

By |2007-07-16T00:00:00-04:00July 16th, 2007|Archive, Life Sciences/Biotech|

Wanted: Michigan Life Sciences, Medical Device CEOs To Join Roundtable

BLOOMFIELD HILLS - CJPS Enterprises, through a contract from the Michigan Economic Development Corporation, will be inviting a few select medical device and life sciences executives to join its Chief Executives Roundtable. The group will be comprised of CEOs, executive directors, general managers, and business owners interested in growing their medical device or life science

By |2006-12-19T00:00:00-05:00December 19th, 2006|Archive, Life Sciences/Biotech|

Michigan Needs To Create Economic Climate To Foster Biotech Growth

LANSING ? At a forum in Lansing Tuesday, leading experts pounded home this point - Michigan needs to create an environment that fosters economic growth for the state's biotech and life science industry that helps all companies, regardless of size, succeed. The forum brought together biotechnology executives, venture capitalists, academicians, policymakers and business leaders from

By |2006-12-12T00:00:00-05:00December 12th, 2006|Archive, Life Sciences/Biotech|

Pfizer To Cut US Sales Force By 20 Percent

NEW YORK - Pfizer Inc. unveiled plans Tuesday to reduce its U.S. sales organization by about 20 percent, an acknowledgement that its current model for marketing drugs to doctors has become too expensive. The company said that despite the cuts, it would maintain "strong support" for big sellers Lipitor and Celebrex, as well as for

By |2006-11-28T00:00:00-05:00November 28th, 2006|Archive, Life Sciences/Biotech|

Aastrom Biosciences Big Losses Continue Due To Clinical Trials Expenses

ANN ARBOR ? Higher expenses due to ongoing clinical trials in the U.S. and Europe, plus added costs for building a new manufacturing facility and paying a severance package to the former CEO, added to the quarterly losses at Aastrom Biosciences. The pharma company, which is developing cells to regenerate growth, lost $4 million for

By |2006-11-14T00:00:00-05:00November 14th, 2006|Archive, Life Sciences/Biotech|

Neogen, Niowave Get Housing Assistance Incentives From State

LANSING ? Neogen Corp. and Niowave will get housing assistance incentives from the Michigan State Housing Development Authority to offer special mortgages and other financial incentives to recruit new employees. The Employer Assisted Housing program at MSHDA helps employers create their own housing benefit program and brings a zero-interest down payment loan of up to

By |2006-11-14T00:00:00-05:00November 14th, 2006|Archive, Life Sciences/Biotech|

CareTech Solutions Signs 5-Year Outsourcing Deal With Colorado Hospital

TROY- Healthcare IT company CareTech Solutions has signed a five-year outsourcing agreement with Yampa Valley Medical Center of Colorado to continue to maintain YVMC's data center operations, applications and communications with physicians. No dollar value was provided. The new outsourcing agreement, effective Oct. 1, continues CareTech Solutions' longstanding relationship with YVMC, which began in January

By |2006-11-14T00:00:00-05:00November 14th, 2006|Archive, Life Sciences/Biotech|

BestNet Communications Announces Agreement For Cancer Treatment

GRAND RAPIDS ? BestNet has cut a deal with the Institut fur Umwelttechnologien GmbH of Berlin to demonstrate the commercial feasibility of its treatment for liver cancer. IUT will provide development and testing services in connection with the accomplishment of the Development Feasibility Phase of its Oncosphere program. Oncosphere is the Best Net?s radioactive microsphere

By |2006-10-25T00:00:00-04:00October 25th, 2006|Archive, Life Sciences/Biotech|

Compuware Covisint Creates Partnership To Access Medical Records

DETROIT - Compuware Covisint has created a strategic partnership with Initiate Systems to provide healthcare professionals with secure access to complete patient identification and medical records, despite where they are located. Covisint's healthcare offering will use Initiate?s Identity Hub software, providing a scalable solution that regional health information organizations, integrated delivery networks and other healthcare

By |2006-10-24T00:00:00-04:00October 24th, 2006|Archive, Life Sciences/Biotech|

Human Tissue Bank Asterand Makes Research Materials Available

DETROIT ? Human tissue bank company Asterand said it is making available new research materials that can be used to study rheumatoid arthritis, osteoarthritis, cancer and other diseases. The company is offering researchers cells that have been isolated from various parts of the body, including synovium from the joints of patients suffering from rheumatoid arthritis

By |2006-10-24T00:00:00-04:00October 24th, 2006|Archive, Life Sciences/Biotech|